France· FR:61886269
ELDISINE 5 mg, poudre pour solution injectable
A vindesine product containing sulfate de vindésine, registered in France by EG LABO - LABORATOIRES EUROGENERICS. The same ATC class is registered in 6 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Vindesine is registered in 6 of 19 countries.
Countries holding a registration under ATC L01CA03 (vindesine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 4 of them publish a price we can compare per daily dose
Vindesine · ATC L01CA03
6 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE DE VINDÉSINE
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- L01CA03
- ATC class
- Vindesine
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009565500741 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vindesine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEldisine 5 mgEG
- SwitzerlandEldisine
- GermanyEldisineStadapharm Gmbh
- SpainENISON 5 MG POLVO PARA SOLUCIoN INYECTABLELaboratorio Stada S.L.
- FinlandEldisineSTADA Nordic ApS
- United KingdomEldisine 5mg powder for solution for injection vialsGenus Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Eldisine
- Spain · Enison
- Italy · Eldisine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a79cef9-5876-42b4-ab06-43d99ba76a2b GET /v1/drugs/2a79cef9-5876-42b4-ab06-43d99ba76a2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61886269",
"date_amm": "2004-03-31",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE DE VINDÉSINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vindesine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.